Haemostatic action of a topical foam-based patch (VELSEAL-T) in haemophiliac patients with external bleeding

1Sachdeva A, Gunasekaran V, Ramya HN, et al. Consensus statement of the Indian Academy of Pediatrics in diagnosis and management of hemophilia. Indian Pediatr 2018; 55: 582–90.SachdevaAGunasekaranVRamyaHNConsensus statement of the Indian Academy of Pediatrics in diagnosis and management of hemophiliaIndian Pediatr2018555829010.1007/s13312-018-1302-8Search in Google Scholar

2Gupta H, Dutta UP, Sengupta PP. The socioeconomic dimensions for the management of haemophilia in India: an empirical study. J Health Manag 2018; 20(1): 38–45. doi: 10.1177/097206341774699.GuptaHDuttaUPSenguptaPPThe socioeconomic dimensions for the management of haemophilia in India: an empirical studyJ Health Manag2018201384510.1177/097206341774699Open DOISearch in Google Scholar

3Dutta A, Dutta TS, Kar S, Kakati S, Dowerah P. Study on clinical presentation of factor deficient patients presenting to a tertiary care centre of North East India. Journal of Medical Science and Clinical Research 2016; 4(7): 11533–38. doi: 10.18535/jmscr/v4i7.57.DuttaADuttaTSKarSKakatiSDowerahPStudy on clinical presentation of factor deficient patients presenting to a tertiary care centre of North East IndiaJournal of Medical Science and Clinical Research201647115333810.18535/jmscr/v4i7.57Open DOISearch in Google Scholar

4Dutta A, Dutta TS, Dey P. Clinical profile of haemophilia patients of Upper Assam – a hospital-based study. J Evol Med Dent Sci 2017;6(37):2990–93. doi: 10.14260/Jemds/2017/645.DuttaADuttaTSDeyPClinical profile of haemophilia patients of Upper Assam – a hospital-based studyJ Evol Med Dent Sci201763729909310.14260/Jemds/2017/645Open DOISearch in Google Scholar

5Rodriguez-Merchan EC. Local fibrin glue and chitosan-based dressings in haemophilia surgery. Blood Coagul Fibrinolysis 2012; 23(6): 473–6. doi: 10.1097/MBC.0b013e3283555379.Rodriguez-MerchanECLocal fibrin glue and chitosan-based dressings in haemophilia surgeryBlood Coagul Fibrinolysis2012236473610.1097/MBC.0b013e3283555379Open DOISearch in Google Scholar

6Misgav M, Kenet G, Martinowitz U. Chitosan-based dressing for the treatment of external/accessible bleedings in children with bleeding tendency. J Pediatr Hematol Oncol 2014;36(2):140–2. doi: 10.1097/MPH.0b013e31828ac8b6.MisgavMKenetGMartinowitzUChitosan-based dressing for the treatment of external/accessible bleedings in children with bleeding tendencyJ Pediatr Hematol Oncol2014362140210.1097/MPH.0b013e31828ac8b6Open DOISearch in Google Scholar

7Dutta A, Das AK. Haemostasis action of VELSEAL-T in a haemophilia A patient with external bleeding. J Haem Pract 2018; 5(1): 4–7. doi: 10.17225/jhp00105.DuttaADasAKHaemostasis action of VELSEAL-T in a haemophilia A patient with external bleedingJ Haem Pract2018514710.17225/jhp00105Open DOISearch in Google Scholar

8Forrest RD. Early history of wound treatment. J R Soc Med 1982; 75: 198–205.ForrestRDEarly history of wound treatmentJ R Soc Med19827519820510.1177/014107688207500310Search in Google Scholar

9Lawrence JC. What materials for dressings? Injury 1982; 13: 500–12. doi: 10.1016/0020-1383(82)90166-8.LawrenceJCWhat materials for dressings?Injury1982135001210.1016/0020-1383(82)90166-8Open DOISearch in Google Scholar

10Piskozub ZT. The efficiency of wound dressing materials as a barrier to secondary bacterial contamination. Br J Plast Surg 1968; 21(4): 387–401. doi: 10.1016/s0007-1226(68)80069-4.PiskozubZTThe efficiency of wound dressing materials as a barrier to secondary bacterial contaminationBr J Plast Surg196821438740110.1016/s0007-1226(68)80069-4Open DOISearch in Google Scholar

11Thomas S, Dawes C, Hay NP. Wound dressing materials—testing and control. Pharm J 1982; 228: 576–8.ThomasSDawesCHayNPWound dressing materials—testing and controlPharm J19822285768Search in Google Scholar

12Seaman S. Dressing selection in chronic wound management. J Am Podiatr Med Assoc 2002; 92(1): 24–33. doi: 10.7547/87507315-92-1-24.SeamanSDressing selection in chronic wound managementJ Am Podiatr Med Assoc2002921243310.7547/87507315-92-1-2411796796Open DOISearch in Google Scholar

13Sood A, Granick MS, Tomaselli NL. Wound dressings and comparative effectiveness data. Adv Wound Care (New Rochelle) 2014; 3(8): 511–29. doi: 10.1089/wound.2012.0401.SoodAGranickMSTomaselliNLWound dressings and comparative effectiveness dataAdv Wound Care (New Rochelle)2014385112910.1089/wound.2012.0401Open DOISearch in Google Scholar

14Robinson BJ. The use of a hydrofibre dressing in wound management. J Wound Care 2000; 9(1): 32–4. doi: 10.12968/jowc.2000.9.1.25941.RobinsonBJThe use of a hydrofibre dressing in wound managementJ Wound Care20009132410.12968/jowc.2000.9.1.25941Open DOISearch in Google Scholar

15Thorn RM, Austin AJ, Greenman J, Wilkins JP, Davis PJ. In vitro comparison of antimicrobial activity of iodine and silver dressings against biofilms. J Wound Care 2009; 18(8): 343–6. doi: 10.12968/jowc.2009.18.8.43635.ThornRMAustinAJGreenmanJWilkinsJPDavisPJIn vitro comparison of antimicrobial activity of iodine and silver dressings against biofilmsJ Wound Care2009188343610.12968/jowc.2009.18.8.43635Open DOISearch in Google Scholar

16Spangler D, Rothenburger S, Nguyen K, et al. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic resistant microorganisms. Surg Infect (Larchmt) 2003; 4(3): 255–62. doi: 10.1089/109629603322419599.SpanglerDRothenburgerSNguyenKIn vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic resistant microorganismsSurg Infect (Larchmt)2003432556210.1089/109629603322419599Open DOISearch in Google Scholar

17Hofman D, Wilson J, Poore S, Cherry G, Ryan T. Can Traumacel be used in the treatment of chronic wounds? J Wound Care 2000; 9(8): 393–6. doi: 10.12968/jowc.2000.9.8.26280.HofmanDWilsonJPooreSCherryGRyanTCan Traumacel be used in the treatment of chronic wounds?J Wound Care200098393610.12968/jowc.2000.9.8.26280Open DOISearch in Google Scholar

18Seyednejad H, Imani M, Jamieson T, Seifalian AM. Topical haemostatic agents. Br J Surg 2008; 95(10): 1197–225. doi: 10.1002/bjs.6357.SeyednejadHImaniMJamiesonTSeifalianAMTopical haemostatic agentsBr J Surg20089510119722510.1002/bjs.6357Open DOISearch in Google Scholar

19Hino M, Ishiko O, Honda KI, et al. Transmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgery. Br J Haematol 2000; 108(1): 194–5. doi: 10.1046/j.1365-2141.2000.01818.x.HinoMIshikoOHondaKITransmission of symptomatic parvovirus B19 infection by fibrin sealant used during surgeryBr J Haematol20001081194510.1046/j.1365-2141.2000.01818.xOpen DOISearch in Google Scholar

20Pope M, Johnston KW. Anaphylaxis after thrombin injection of a femoral pseudoaneurysm: recommendations for prevention. J Vasc Surg 2000; 32(1): 190–1. doi: 101067/mva.2000.106498.PopeMJohnstonKWAnaphylaxis after thrombin injection of a femoral pseudoaneurysm: recommendations for preventionJ Vasc Surg20003211901101067/mva.2000.106498Open DOISearch in Google Scholar

21Tadokoro K, Ohtoshi T, Takafuji S, et al. Topical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin test studies. J Allergy Clin Immunol 1991; 88(4): 620–9. doi: 10.1016/0091-6749(91)90156-i.TadokoroKOhtoshiTTakafujiSTopical thrombin-induced IgE-mediated anaphylaxis: RAST analysis and skin test studiesJ Allergy Clin Immunol1991884620910.1016/0091-6749(91)90156-iOpen DOISearch in Google Scholar

22Wai Y, Tsui V, Peng Z, Richardson R, Oreopoulos D, Tarlo SM. Anaphylaxis from topical bovine thrombin (Thrombostat) during haemodialysis and evaluation of sensitization among a dialysis population. Clin Exp Allerg 2003; 33(12): 1730–4. doi: 10.1111/j.1365-2222-2003.01806.x.WaiYTsuiVPengZRichardsonROreopoulosDTarloSMAnaphylaxis from topical bovine thrombin (Thrombostat) during haemodialysis and evaluation of sensitization among a dialysis populationClin Exp Allerg200333121730410.1111/j.1365-2222-2003.01806.xOpen DOISearch in Google Scholar

23Schuhmacher C, Pratschke J, Weiss S, et al. Safety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleeding. Med Devices (Auckl) 2015; 8: 167–74. doi: 10.2147/MDER.S79556.SchuhmacherCPratschkeJWeissSSafety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleedingMed Devices (Auckl)201581677410.2147/MDER.S79556438678925878513Open DOISearch in Google Scholar

24Glineur D, Hendrikx M, Krievins D, et al. A randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleeding. Med Devices (Auckl) 2018; 11: 65–75. doi: 10.2147/MDER.S145651.GlineurDHendrikxMKrievinsDA randomized, controlled trial of Veriset™ hemostatic patch in halting cardiovascular bleedingMed Devices (Auckl)201811657510.2147/MDER.S145651584630229563844Open DOISearch in Google Scholar

25Kranokpiraksa P, Pavcnik D, Kakizawa H, et al. Hemostatic efficacy of chitosan-based bandage for closure of percutaneous arterial access sites: An experimental study in heparinised sheep model. Radiol Oncol 2010; 44(2): 86–91. doi: 10.2478/v10019-010-0021-0.KranokpiraksaPPavcnikDKakizawaHHemostatic efficacy of chitosan-based bandage for closure of percutaneous arterial access sites: An experimental study in heparinised sheep modelRadiol Oncol2010442869110.2478/v10019-010-0021-0342368622933896Open DOISearch in Google Scholar

26Binet Q, Lambert C, Sacré L, Eeckhoudt S, Hermans C. Successful management of acquired hemophilia A associated with bullous pemphigoid: a case report and review of the literature. Case Rep Hematol 2017; 2017: 2057019. doi: 10.1155/2017/2057019.BinetQLambertCSacréLEeckhoudtSHermansCSuccessful management of acquired hemophilia A associated with bullous pemphigoid: a case report and review of the literatureCase Rep Hematol201720172057019.10.1155/2017/2057019538780328458935Open DOISearch in Google Scholar